Healthcare provider profile · identity verified

Christopher John Warnimont, MD

Internal Medicine · CLEMMONS, NC · NPI 1760485486

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	494	133
Amlodipine Besylate	Amlodipine Besylate	464	118
Rosuvastatin Calcium	Rosuvastatin Calcium	303	79
Levothyroxine Sodium	Levothyroxine Sodium	254	57
Losartan Potassium	Losartan Potassium	229	58
Metformin Hcl Er	Metformin Hcl	228	66
Escitalopram Oxalate	Escitalopram Oxalate	205	50
Lisinopril	Lisinopril	185	52
Omeprazole	Omeprazole	182	53
Hydrochlorothiazide	Hydrochlorothiazide	176	49
Alprazolam	Alprazolam	172	39
Simvastatin	Simvastatin	154	37
Trazodone Hcl	Trazodone Hcl	148	34
Metoprolol Succinate	Metoprolol Succinate	137	40
Pantoprazole Sodium	Pantoprazole Sodium	129	40
Carvedilol	Carvedilol	121	33
Sertraline Hcl	Sertraline Hcl	108	25
Bupropion Xl	Bupropion Hcl	104	18
Gabapentin	Gabapentin	104	23
Pravastatin Sodium	Pravastatin Sodium	99	27
Alendronate Sodium	Alendronate Sodium	94	27
Duloxetine Hcl	Duloxetine Hcl	91	22
Metformin Hcl	Metformin Hcl	91	22
Farxiga	Dapagliflozin Propanediol	89	15
Montelukast Sodium	Montelukast Sodium	89	23
Celecoxib	Celecoxib	87	23
Allopurinol	Allopurinol	86	19
Eliquis	Apixaban	80	15
Albuterol Sulfate Hfa	Albuterol Sulfate	78	42
Enalapril Maleate	Enalapril Maleate	78	19
Potassium Chloride	Potassium Chloride	68	22
Furosemide	Furosemide	63	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	15
Prednisone	Prednisone	56	43
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	55	12
Chlorthalidone	Chlorthalidone	54	12
Ramipril	Ramipril	52	13
Tamsulosin Hcl	Tamsulosin Hcl	50	13
Tramadol Hcl	Tramadol Hcl	49	11
Fluticasone Propionate	Fluticasone Propionate	48	18
Mounjaro	Tirzepatide	48	suppressed
Ozempic	Semaglutide	46	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	11
Metoprolol Tartrate	Metoprolol Tartrate	43	12
Clonazepam	Clonazepam	42	12
Nebivolol Hcl	Nebivolol Hcl	41	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	37
Jardiance	Empagliflozin	39	suppressed
Famotidine	Famotidine	38	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	suppressed
Meloxicam	Meloxicam	38	17
Xarelto	Rivaroxaban	36	suppressed
Atenolol	Atenolol	34	suppressed
Pregabalin	Pregabalin	33	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	11
Ezetimibe	Ezetimibe	30	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Cephalexin	Cephalexin	26	20
Donepezil Hcl	Donepezil Hcl	26	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	13
Benazepril Hcl	Benazepril Hcl	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	11
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	20
Verapamil Er	Verapamil Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Valsartan	Valsartan	20	suppressed
Finasteride	Finasteride	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	16
Promethazine Hcl	Promethazine Hcl	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	16	suppressed
Methadone Hcl	Methadone Hcl	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Telmisartan	Telmisartan	16	suppressed
Azithromycin	Azithromycin	15	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	15	suppressed
Cefdinir	Cefdinir	14	14
Diazepam	Diazepam	14	suppressed
Estradiol	Estradiol	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Lexapro	Escitalopram Oxalate	12	suppressed
Nystatin	Nystatin	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Clarithromycin	Clarithromycin	11	11
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Irbesartan	Irbesartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error